Hormone Replacement Therapy & Breast Cancer: Myth vs. Fact
Here’s a breakdown of the key information from the provided text, focusing on hormone replacement therapy (HRT) and breast cancer risk:
Key Takeaways:
* HRT can be safe and effective: Reputable organizations like NAMS and FIGO state that HRT, when appropriately indicated and monitored, can be safe and effective, especially when started soon after menopause and in women without contraindications.
* Myth: All HRT causes breast cancer: This is FALSE. The risk depends on the type of HRT, the duration of treatment, and the patient’s individual health history. Estrogen-only therapy (for women without a uterus) has a different impact then combined estrogen-progesterone therapy.
* Truth: Long-term combined HRT may increase risk: Prolonged use (over 5 years) of combined estrogen and progesterone can increase breast cancer risk.
* Myth: Family history is an absolute contraindication: This is FALSE. A family history of breast cancer requires increased caution and monitoring, but doesn’t automatically disqualify someone from HRT. A doctor needs to assess each case individually.
* Truth: Individual assessment is crucial: A thorough evaluation of age, family history, breast density, and existing health conditions is essential before starting HRT.
In essence, the text emphasizes that HRT isn’t a one-size-fits-all situation. The risks and benefits need to be carefully weighed for each individual patient by a healthcare professional.